Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
Janssen (China) Research & Development Center
IN-JET APS
Custom Pharmaceuticals Limited
Prof. Jacques SCHRENZEL
Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
Advanced Life Solutions
JMI Laboratories
Universitatea de Medicina si Farmacie Iuliu Hatieganu
The Fred Hollows Foundation, Australia
Physip S.A
Hospital Samaritano Paulista
Dr. Praveen B.H
Markham Stouffville Hospital
UZ Leuven, campus Pellenberg (Belgium)
Nestlé Health Science Belgium
Hazelden Betty Ford Foundation
Pedro Gamito
Fogarty International Center of the National Institute of Health
Stannah Stairlifts
Familien Hede Nielsens Fond
View Full List
Medical Conditions
Closure; Foramen Ovale
Epidemic Hemorrhagic Fever
Fracture Dislocation of Cervical Spine
Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Ewing's Family Tumors
Predictors of Atrial Fibrillation Recurrences
Gullian Barre Syndrome
Chlamydophila Infections
Childhood Langerhans Cell Histiocytosis
Painless Hysteroscopy
Endocarditis Infective
Cutaneous Leiomyomata With Uterine Leiomyomata
Skull Base Neoplasms
Psoriasis, Arthritic
Multisystem Proteinopathy
Fetus or Neonate Affected by External Version Before Labor
Pulmonary Adenocarcinoma
Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
Spine Surgeries
Tay-Sachs Disease Ganglioside
View Full List
Drug Interventions
Cereport
Mocetinostat - Recommended Phase 2 Dose (70 mg)
Qingkailing injection 40 ml
Neihulizumab
Adapalene Gel 0.3%
EFV +TVA
Estradiol+Drospirenone
Naltrexone 50 mg/day + Cognitive Behavioral Therapy
Semapimod
Vehicle
Esomeprazole 40mg before
NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
Redifferentiation with retinoid acid
Glimepiride
PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
Chemotherapeutic Agent
Azelastine hydrochloride (BAYR9258)
Adriamycin
High dose pantoprazole infusion
Palliative care group first-line scheme
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Brazil
Contract Research Organizations in China
Contract Research Organizations in Ecuador
Contract Research Organizations in Luxembourg
Contract Research Organizations in Nigeria
Contract Research Organizations in Qatar
Contract Research Organizations in Senegal
Contract Research Organizations in Slovakia
Contract Research Organizations in Taiwan
Contract Research Organizations in Ukraine
Contract Research Organizations in Uzbekistan
Contract Research Organizations in Vietnam
CRO list by country
CROs in Malawi
SGS
All CROs in Malawi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe